Skip to main content
. Author manuscript; available in PMC: 2018 May 7.
Published in final edited form as: Pharmacol Ther. 2011 Jan 26;130(3):283–309. doi: 10.1016/j.pharmthera.2011.01.005

Table 6.

Pain during chronic inflammation.

Drug Dose Route Reference
CFA inflammation
Agonist
 NMDA 0.01–0.5 mM, 20 μl i.pl. Du et al., 2003
 Kainate 1 mM, 20 μl i.pl. Du et al., 2006
Antagonist
 DON 0.8–800 mM (0.02–20 μmol/25 μl) i.pl. Miller et al., 2010b
 MK 801 0.5 mM, 20 μl i.pl. Du et al., 2003
 CNQX 0.1 mM, 20 μl i.pl. Du et al., 2006
 MK 801 10 nM (1 pmol/100 μl) i.pl. Leem et al., 2001
 MPEP 10–30 mM (100–300 nmol/10 μl) i.pl. Walker et al., 2001
Formalin
Agonist
 Glutamate, NMDA, AMPA, or kainate 20 mM; (1 μmol/50 μl) i.pl. Aumeerally et al., 2004